Astra Stockpiles Vaccine That Could Speed Up Biden Timeline (1)

March 6, 2021, 10:45 AM

AstraZeneca Plc has begun stockpiling its Covid-19 vaccine for use in the U.S., providing a potential supply boost that could speed up President Joe Biden’s inoculation timetable, should the company win regulatory authorization.

A company executive said this week it has begun production and expects to have 30 million doses ready for U.S. distribution, once it’s approved by the U.S. Food and Drug Administration. AstraZeneca hasn’t yet applied to the FDA and hasn’t said when it will, but the U.K.-based company expects to produce 15 to 25 million doses per month for the U.S. after that.

If the ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.